Denosumab and teriparatide transitions in postmenopausal osteoporosis (the DATA-Switch study): extension of a randomised controlled trial. [electronic resource]
Producer: 20151109Description: 1147-55 p. digitalISSN:- 1474-547X
- Aged
- Antibodies, Monoclonal, Humanized -- administration & dosage
- Bone Density -- drug effects
- Bone Density Conservation Agents -- administration & dosage
- Denosumab
- Drug Administration Schedule
- Drug Substitution
- Drug Therapy, Combination
- Female
- Follow-Up Studies
- Humans
- Middle Aged
- Osteoporosis, Postmenopausal -- drug therapy
- Single-Blind Method
- Teriparatide -- administration & dosage
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.